Analyst Ratings for Ionis Pharmaceuticals (IONS)
IONS Rating Summary
IONS Price Target Summary
- Highest: $125.00 (H.C. Wainwright)
- Lowest: $46.00 (UBS)
- Average: $91.82
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$91.82 (+68.8%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
Rating Score: 6.4 / 10
Percentile Rank: 67%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/16/2026 | Wolfe Research | Andy Chen | Downgrade | Peerperform (Outperform) |
N/A (N/A) |
54.93 (54.39) |
-0.98% | Details |
| 5/20/2026 | JPMorgan | Jessica Fye | New Coverage | Overweight (N/A) |
90.00 (N/A) |
72.52 (54.39) |
-25% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
